The Multimillion-Dollar Friendship Industry Has a Big Flaw
If you're a lonely adult in an American city, please know that people are trying very hard to help you. A few examples: The organization Project Gather hosts food-centered hangouts—potlucks, bake sales, mushroom foraging—across the country. The company Timeleft, operating in more than 300 cities, matches groups of five strangers for dinner every Wednesday. Belong Center offers 'Belong Circles,' 90-minute gatherings led by 'trained community architects.' Block Party USA seems to, um—advocate for the concept of block parties?
Ventures such as these make up a growing friendship industry, and they claim a lofty goal: Not only do they want to get people off their phone and out of the house; they want nothing less than to cure Americans of alienation. 'Eating with others can bring joy, build interpersonal connections, and ultimately help solve the loneliness epidemic in the U.S.,' Project Gather declares. Block Party USA considers itself an 'actionable cure for our country's loneliness, social isolation, divisiveness, and the youth mental health crisis.' Ambitious! But I have some notes.
First, it must be said: Research doesn't back up the idea that America is experiencing a loneliness epidemic, or even that overall loneliness rates are worse now than they've generally been throughout history.
Of course, plenty of people do report feeling lonely—particularly young adults, a group that may actually be lonelier than they used to be. And many of these endeavors explicitly or implicitly target Gen Z, a cohort that does seem to struggle with interpersonal trust and vulnerability, and therefore could probably use some help connecting. If only it were as easy as getting them in the same room.
[Read: The myth of a loneliness epidemic]
Most of these start-ups appear to rely on a common assumption: Loneliness results from a lack of friends, and to make new friends, one should meet new people. But we don't fully know what makes a person more or less lonely. Loneliness and time spent alone don't seem to be closely correlated; different people crave different amounts of socializing, and not all socializing is equally fulfilling. When researchers at the Harvard Graduate School of Education surveyed 1,500 American adults about loneliness, they found that people cited a number of struggles, not all clearly related to a friend shortage: 65 percent of those who were lonely said they felt existentially alone, separate from others or the world; 60 percent said their insecurity or mental health had made connection more difficult; 57 percent said they couldn't share their true self. Other studies suggest that very few people have no friends, and that the average number of friends people have has remained fairly stable over time.
The problem with relationships is often one of quality rather than quantity. One firm believer in this principle is Shasta Nelson, who writes about friendship and hosts a podcast called Frientimacy. The title is a nod to what she believes many people are hungry for: not friends, per se, but real intimacy with those friends. 'We don't need to meet more people,' she told me. 'We need to feel more met by the people we already know.'
Achieving frientimacy, she argues, requires three things: consistency, positivity, and vulnerability. The friendship industry tends to start and end with mere presence: You have to show up. But a single paint-and-sip does not a best friend make. Jeffrey A. Hall, a University of Kansas communication professor, has found in his work that going from strangers to casual friends typically takes 40 to 60 hours spent together; moving to actual friends takes 80 to 100 hours, and forming a good friendship tends to take about 200 hours altogether. Ideally, a friendship-event attendee knows that if they meet someone they like, they should reach out again. What about the time after that—and after that? Without another shared context or network to put them in regular proximity, consistency is difficult to attain.
[Read: The six forces that fuel friendship]
American culture has few models for how early friendship development works, Nelson told me. People tend to understand that after a good first date, they need to schedule the next meetup—soon, or they'll lose momentum. With platonic prospects, though, many people don't know how to put in the work. 'One of the big myths,' she said, is 'that we just have to meet the right person. We just need to keep being in the room, and eventually we'll find our best friend.' Instead of seeking more and more people, hoping for a spark, maybe you're better off working on the friendships that you already have—you know, the ones you're neglecting while playing badminton with strangers.
This is where positivity, another one of Nelson's pillars, comes in: the measure of how good a given friendship is making you feel. It's actually the key to consistency, because you won't be motivated to clear space in a hectic schedule—to pay the babysitter, to do the commute—if you didn't leave the last hang feeling seen. Nelson hears a lot of complaints about consistency being the hardest node of the triad to achieve, but for years now, she's been asking participants to assess their own strength in each of the three areas—and she's found that positivity is the area in which participants perform most poorly. So many people, she observed, are overwhelmed and burned out; they might show up and cross 'friend time' off their list without really giving those friends their full attention. Or they're so nervous and afraid of rejection that they focus on themselves while socializing, not on how to make others feel valued. And if they're too guarded to really open up—to achieve the third pillar, vulnerability—how can they expect the other person to do so either?
Hypothetically, an anti-loneliness start-up could design meetups with these principles in mind: supporting the slow build of connection over time; encouraging warmth, sharing, and vocal affirmation. Nelson herself ran a 'friendship accelerator' program back in 2008, in which she matched participants into small groups and had them commit to 10 full weeks of structured gatherings. Each one ended with everyone in a circle, telling the person on their right one thing they appreciated about them. At least one of those groups, she told me, is still close. At the same time, she knows that even the most perfectly curated series of get-togethers isn't likely to fix anyone's social life. She compared it to working out: You don't really start to feel the benefits until you've stuck with it enough to get in shape. 'We have to see our social health not just as an event here and there, but like a lifestyle,' she told me, 'that we are training for and getting stronger in.'
[Read: Americans are hoarding their friends]
The loneliness industrial complex is unlikely to sustain a lifetime of intentional friendship. But further, it isn't equipped to address the structural issues plaguing many lonely people—especially young adults. Hosting social events won't make rent any cheaper or higher education more affordable, which might allow more young people to live near friends rather than moving back in with their parents. It won't cut down on people's working hours so they can spend more time with loved ones. It won't fix the mental-health-treatment gap, which exists because providers tend to focus on children and adolescents or end up treating middle-aged and older adults, leaving young adults underserved. It won't transform the architecture of cities—build larger housing units, say, so people can host groups; improve public transportation so they can easily reach friends; open new 'third places,' public areas where people can socialize for free.
Imperfect measures are better than none. Still: A whole lot of resources—whether from investors or individual donors or pro bono efforts—are being dumped into the friendship industry. TimeLeft, backed by venture capital, has raised more than $2 million since 2020; according to a story in New York magazine earlier this year, Belong Center has gathered at least $1,750,000. Hinge's 'One More Hour' initiative is investing $1 million in existing social clubs—some of which host events, such as 'reading parties,' that sound highly likely to be one-off experiences.
And although some of these meetups are free to attendees, others require entry fees or memberships. Take the Brooklyn-based Sprout Society's upcoming 'Together We Dink': A Pickleball Experience event: A ticket that includes playing, food, and drinks costs $250. Across the nation, people yearning for some kind of community are really trying—they're making time, getting dressed up, shelling out—all for a highly imperfect solution. At best, these enterprises offer helpful venues for meeting interesting people, whether or not you'll be forever friends or even have much in common. At worst, they're expensive distractions, offering a false promise of shiny new connections at the expense of old pals—the ones who have been there all along.
Article originally published at The Atlantic
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hamilton Spectator
43 minutes ago
- Hamilton Spectator
22 Palestinians killed in Gaza as Israeli forces fire on crowds at food aid sites, medics say
CAIRO (AP) — Israeli forces killed at least 22 people and wounded 20 others, many while attempting to get desperately needed food aid in southern Gaza on Monday, according to witnesses, hospitals, and Gaza's Health Ministry. Nasser Hospital in Khan Younis said it received the bodies of 11 people who were shot while returning from an aid site associated with Israeli and U.S.-backed Gaza Humanitarian Fund in southern Gaza, part of a deadly pattern that has killed more than 500 Palestinians in the chaotic and controversial aid distribution program over the past month. Ten others were killed at a United Nations aid warehouse in northern Gaza, according to the Health Ministry. The southern Gaza strike happened around 3 kilometers (1.8 miles) from the GHF site in the city of Khan Younis, as Palestinians returned from the site along one of the only accessible routes. Palestinians are often forced to travel long distances to access the GHF hubs in hopes of obtaining aid. Witnesses recount firings by troops Yousef Mahmoud Mokheimar was walking along with dozens others when he saw troops in vehicles and tanks racing toward them. At the beginning they fired warning shots in air, before firing at the crowds, he said. 'They fired at us indiscriminately,' he said, adding that he was shot in his leg, and a man was also shot while attempting to rescue him. He said he saw troops detaining six people, including three children, and it wasn't clear what happened to them. 'We don't know whether they are still alive,' he said. Monzer Hisham Ismail, another witness, said troops attacked the crowds while returning from the GHF hub in eastern Khan Younis. 'We were returning from the American aid hub … we were targeted by (the Israeli) artillery,' he said. Nasser Hospital said another person was killed near a GHF hub in the southern city of Rafah. The Israeli military said it was reviewing information about the attacks. In the past, the military has said it fires warning shots at people who move suspiciously or get too close to troops, including while collecting aid. Israel wants the GHF to replace a system coordinated by the United Nations and international aid groups. Along with the United States, Israel has accused the militant Hamas group of stealing aid and using it to prop up its rule in the enclave. The U.N. denies there is systematic diversion of aid. The Israeli military said it had recently taken steps to improve organization in the area, including the installation of new fencing, signage and the opening of additional routes to access aid. Israel says it only targets militants and blames civilian deaths on Hamas, accusing the militants of hiding among civilians because they operate in populated areas. Strikes in and around Gaza City intensify In northern Gaza, at least 10 Palestinians were killed in an Israeli strike on an aid warehouse in Gaza City, according to the Health Ministry's ambulance and emergency service. It wasn't immediately clear whether there was aid at the warehouse. The strike in Gaza City came as the military intensified its bombardment campaign across the city and the nearby Jabaliya refugee camp. On Sunday and Monday, Israel issued widespread evacuation orders for large swaths of northern Gaza. Palestinians reported massive bombing overnight into Monday morning, describing the fresh attacks as a 'scorched earth' campaign that targeted mostly empty buildings and civilian infrastructure above the ground. 'They destroy whatever left standing … the sound of bombing hasn't stopped,' said Mohamed Mahdy, a Gaza City resident who fled his damaged house Monday morning. Fares Awad, head of the Health Ministry's emergency and ambulance services in northern Gaza, said that most of Gaza City and Jabaliya have become inaccessible and ambulances were unable to respond to distress calls from people trapped in the rubble. The Israeli military said it had taken multiple steps to notify civilians of operations to target Hamas' military command and control centers in northern Gaza. ___ Lidman reported from Tel Aviv, Israel. ___ Follow the AP's war coverage at . Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .


The Hill
an hour ago
- The Hill
22 Palestinians killed in Gaza as Israeli forces fire on crowds at food aid sites, medics say
CAIRO (AP) — Israeli forces killed at least 22 people and wounded 20 others, many while attempting to get desperately needed food aid in southern Gaza on Monday, according to witnesses, hospitals, and Gaza's Health Ministry. Nasser Hospital in Khan Younis said it received the bodies of 11 people who were shot while returning from an aid site associated with Israeli and U.S.-backed Gaza Humanitarian Fund in southern Gaza, part of a deadly pattern that has killed more than 500 Palestinians in the chaotic and controversial aid distribution program over the past month. Ten others were killed at a United Nations aid warehouse in northern Gaza, according to the Health Ministry. The southern Gaza strike happened around 3 kilometers (1.8 miles) from the GHF site in the city of Khan Younis, as Palestinians returned from the site along one of the only accessible routes. Palestinians are often forced to travel long distances to access the GHF hubs in hopes of obtaining aid. Yousef Mahmoud Mokheimar was walking along with dozens others when he saw troops in vehicles and tanks racing toward them. At the beginning they fired warning shots in air, before firing at the crowds, he said. 'They fired at us indiscriminately,' he said, adding that he was shot in his leg, and a man was also shot while attempting to rescue him. He said he saw troops detaining six people, including three children, and it wasn't clear what happened to them. 'We don't know whether they are still alive,' he said. Monzer Hisham Ismail, another witness, said troops attacked the crowds while returning from the GHF hub in eastern Khan Younis. 'We were returning from the American aid hub … we were targeted by (the Israeli) artillery,' he said. Nasser Hospital said another person was killed near a GHF hub in the southern city of Rafah. The Israeli military said it was reviewing information about the attacks. In the past, the military has said it fires warning shots at people who move suspiciously or get too close to troops, including while collecting aid. Israel wants the GHF to replace a system coordinated by the United Nations and international aid groups. Along with the United States, Israel has accused the militant Hamas group of stealing aid and using it to prop up its rule in the enclave. The U.N. denies there is systematic diversion of aid. The Israeli military said it had recently taken steps to improve organization in the area, including the installation of new fencing, signage and the opening of additional routes to access aid. Israel says it only targets militants and blames civilian deaths on Hamas, accusing the militants of hiding among civilians because they operate in populated areas. In northern Gaza, at least 10 Palestinians were killed in an Israeli strike on an aid warehouse in Gaza City, according to the Health Ministry's ambulance and emergency service. It wasn't immediately clear whether there was aid at the warehouse. The strike in Gaza City came as the military intensified its bombardment campaign across the city and the nearby Jabaliya refugee camp. On Sunday and Monday, Israel issued widespread evacuation orders for large swaths of northern Gaza. Palestinians reported massive bombing overnight into Monday morning, describing the fresh attacks as a 'scorched earth' campaign that targeted mostly empty buildings and civilian infrastructure above the ground. 'They destroy whatever left standing … the sound of bombing hasn't stopped,' said Mohamed Mahdy, a Gaza City resident who fled his damaged house Monday morning. Fares Awad, head of the Health Ministry's emergency and ambulance services in northern Gaza, said that most of Gaza City and Jabaliya have become inaccessible and ambulances were unable to respond to distress calls from people trapped in the rubble. The Israeli military said it had taken multiple steps to notify civilians of operations to target Hamas' military command and control centers in northern Gaza. ___ Lidman reported from Tel Aviv, Israel. ___ Follow the AP's war coverage at


Miami Herald
an hour ago
- Miami Herald
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older CAMBRIDGE, MA / ACCESS Newswire / June 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive results from a Phase 3 efficacy study (P304) evaluating the relative vaccine efficacy (rVE) against influenza illness of mRNA-1010, the Company's seasonal influenza (flu) vaccine candidate, compared to a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older. mRNA-1010 achieved the most stringent superiority criterion prespecified in the protocol, with an rVE of 26.6% (95% CI; 16.7%, 35.4%) in the overall study population. Additionally, strong rVE was observed for each influenza strain contained in the vaccine, including A/H1N1 (rVE=29.6%), A/H3N2 (rVE=22.2%), and the B/Victoria lineages (rVE=29.1%). Subgroup analyses confirmed a consistently strong rVE point estimate across age groups, risk factors and previous influenza vaccination status. In participants aged 65 years and older, mRNA-1010 demonstrated an rVE of 27.4%. "Today's strong Phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in older adults. The severity of this past flu season underscores the need for more effective vaccines," said Stéphane Bancel, Chief Executive Officer of Moderna. "An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines." In a previous Phase 3 study, mRNA-1010 had already demonstrated superior seroconversion rates and geometric mean titer ratios (GMR) against all strains included in the vaccine compared to both high-dose and standard-dose licensed seasonal influenza vaccine. [1] According to the CDC, seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-2025 season. [2] More than 600,000 Americans were hospitalized due to flu-related illness last year, leading to substantial direct and indirect costs, as well as widespread disruption to daily life and work. [3] P304 ( NCT06602024 ) is a Phase 3, randomized, observer-blind, active-controlled, case-driven, pivotal efficacy, immunogenicity and safety study. The trial enrolled 40,805 adults aged 50 years and older across 11 countries. Participants were randomly assigned to receive either a single dose of mRNA-1010 or a standard-dose licensed comparator, with a median follow-up of six months. Safety and tolerability of mRNA-1010 were consistent with reported results from a previous Phase 3 study. [4] The majority of solicited adverse reactions (SARs) were mild. Injection site pain was the most common local SAR, and fatigue, headache and myalgia were the most common systemic SARs reported. There were no significant differences between the groups in the rates of unsolicited adverse events, serious adverse events, or adverse events of special interest. Moderna plans to present these data at an upcoming medical conference and submit for peer-reviewed publication. The Company will engage with regulators on filing submissions for mRNA-1010. About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines. Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna's engagement with regulators on filing submissions for its standalone flu vaccine candidate; and the efficacy, safety and tolerability of mRNA-1010. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading "Risk Factors" in Moderna's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC's website at . Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date of this press release. Moderna Contacts Media: Chris RidleyHead of Global Media Relations+1 Investors: Lavina TalukdarSenior Vice President & Head of Investor Relations+1 SOURCE: Moderna, Inc.